Cited by 13Virus-based gene therapy researchRNA Interference and Gene DeliveryGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

RFX1 and RFX3 Transcription Factors Interact with the D Sequence of Adeno-Associated Virus Inverted Terminal Repeat and Regulate AAV Transduction

Open access
Julien, Laura, Chassagne, Julie, Peccate, Cécile, Lorain, Stéphanie, Piétri-Rouxel, France, Danos, Olivier, Benkhelifa-Ziyyat, Sofia·2018·Scientific Reports

Abstract

Adeno-associated virus (AAV) transduction efficiency depends on the way in which cellular proteins process viral genomes in the nucleus. In this study, we have investigated the binding of nuclear proteins to the double stranded D (dsD) sequence of the AAV inverted terminal repeat (ITRs) by electromobility shift assay. We present here several lines of evidence that transcription factors belonging to the RFX protein family bind specifically and selectively to AAV2 and AAV1 dsD sequences. Using supershift experiments, we characterize complexes containing RFX1 homodimers and RFX1/RFX3 heterodimers. Following transduction of HEK-293 cells, the AAV genome can be pulled-down by RFX1 and RFX3 antibodies. Moreover, our data suggest that RFX proteins which interact with transcriptional enhancers of several mammalian DNA viruses, can act as regulators of AAV mediated transgene expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-18604-3

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The AAV ITR interacts with host proteins and can stimulate anti-viral and DNA damage response pathways.

    “it is known that the AAV ITR interacts with a number of host proteins and can stimulate anti-viral and DNA damage response pathways.12–16”

    From Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression (2020) · cites this paper as [12]

    The Introduction (page unavailable) says that several host proteins bind the AAV ITR, including proteins active in double-strand break repair. It does not say that the ITR stimulates antiviral or DNA damage response pathways; the repair proteins are described as recognizing and processing the ITR instead. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Sanlioglu, S., Monick, M. M., Luleci, G., Hunninghake, G. W. & Engelhardt, J. F. Rate limiting steps of AAV transduction and implications for human gene therapy. Curr Gene Ther 1, 137–147 (2001). · DOI
  2. Weitzman, M. D., Carson, C. T., Schwartz, R. A. & Lilley, C. E. Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst) 3, 1165–1173, https://doi.org/10.1016/j.dnarep.2004.03.018 (2004). · DOI
  3. Davidoff, A. M., Ng, C. Y., Zhou, J., Spence, Y. & Nathwani, A. C. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood 102, 480–488, https://doi.org/10.1182/blood-2002-09-2889 (2003). · DOI · Paper page
  4. Flotte, T. R. et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 268, 3781–3790 (1993). · DOI
  5. Srivastava, A. In vivo tissue-tropism of adeno-associated viral vectors. Curr Opin Virol 21, 75–80, https://doi.org/10.1016/j.coviro.2016.08.003 (2016). · DOI
  6. Zentilin, L., Marcello, A. & Giacca, M. Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. J Virol 75, 12279–12287, https://doi.org/10.1128/JVI.75.24.12279-12287.2001 (2001). · DOI · Paper page
  7. Inagaki, K., Ma, C., Storm, T. A., Kay, M. A. & Nakai, H. The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice. J Virol 81, 11304–11321, https://doi.org/10.1128/JVI.01225-07 (2007). · DOI
  8. Choi, V. W., McCarty, D. M. & Samulski, R. J. Host cell DNA repair pathways in adeno-associated viral genome processing. J Virol 80, 10346–10356, https://doi.org/10.1128/JVI.00841-06 (2006). · DOI · Paper page
  9. Duan, D., Yue, Y. & Engelhardt, J. F. Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue. J Virol 77, 4751–4759 (2003). · DOI
  10. Song, S., Laipis, P. J., Berns, K. I. & Flotte, T. R. Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle. Proc Natl Acad Sci USA 98, 4084–4088, https://doi.org/10.1073/pnas.061014598 (2001). · DOI
  11. Cataldi, M. P. & McCarty, D. M. Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes. J Virol 84, 8673–8682, https://doi.org/10.1128/JVI.00641-10 (2010). · DOI
  12. Qing, K. et al. Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol 75, 8968–8976, https://doi.org/10.1128/JVI.75.19.8968-8976.2001 (2001). · DOI · Paper page
  13. Qing, K. et al. Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo. J Virol 77, 2741–2746 (2003). · DOI
  14. Jayandharan, G. R. et al. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Hum Gene Ther 21, 271–283, https://doi.org/10.1089/hum.2009.100 (2010). · DOI
  15. Ling, C. et al. Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. J Virol 89, 952–961, https://doi.org/10.1128/JVI.02581-14 (2015). · DOI · Paper page
  16. Jayandharan, G. R. et al. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy. Proc Natl Acad Sci USA 108, 3743–3748, https://doi.org/10.1073/pnas.1012753108 (2011). · DOI
  17. Dean, J., Plante, J., Huggins, G. S., Snyder, R. O. & Aikawa, R. Role of cyclic AMP-dependent kinase response element-binding protein in recombinant adeno-associated virus-mediated transduction of heart muscle cells. Hum Gene Ther 20, 1005–1012, https://doi.org/10.1089/hum.2009.054 (2009). · DOI
  18. Gajiwala, K. S. et al. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature 403, 916–921, https://doi.org/10.1038/35002634 (2000). · DOI
  19. Emery, P. et al. A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol Cell Biol 16, 4486–4494 (1996). · DOI
  20. Morotomi-Yano, K. et al. Human regulatory factor X 4 (RFX4) is a testis-specific dimeric DNA-binding protein that cooperates with other human RFX members. J Biol Chem 277, 836–842, https://doi.org/10.1074/jbc.M108638200 (2002). · DOI
  21. Choksi, S. P., Lauter, G., Swoboda, P. & Roy, S. Switching on cilia: transcriptional networks regulating ciliogenesis. Development 141, 1427–1441, https://doi.org/10.1242/dev.074666 (2014). · DOI
  22. Iwama, A. et al. Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains. Mol Cell Biol 19, 3940–3950 (1999). · DOI
  23. Nakayama, A. et al. Role for RFX transcription factors in non-neuronal cell-specific inactivation of the microtubule-associated protein MAP1A promoter. J Biol Chem 278, 233–240, https://doi.org/10.1074/jbc.M209574200 (2003). · DOI
  24. Reith, W. et al. RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol Cell Biol 14, 1230–1244 (1994). · DOI
  25. Siegrist, C. A. & Mach, B. Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genes. Eur J Immunol 23, 2903–2908, https://doi.org/10.1002/eji.1830231126 (1993). · DOI
  26. Reinhold, W. et al. The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus enhancer, and to regulatory regions of several distinct viral genes. Mol Cell Biol 15, 3041–3048 (1995). · DOI
  27. Sáfrány, G. & Perry, R. P. Transcription factor RFX1 helps control the promoter of the mouse ribosomal protein-encoding gene rpL30 by binding to its alpha element. Gene 132, 279–283 (1993). · DOI
  28. Liu, M., Lee, B. H. & Mathews, M. B. Involvement of RFX1 protein in the regulation of the human proliferating cell nuclear antigen promoter. J Biol Chem 274, 15433–15439 (1999). · DOI
  29. David, E., Garcia, A. D. & Hearing, P. Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation. J Biol Chem 270, 8353–8360 (1995). · DOI
  30. Kobr, M., Reith, W., Herrero-Sanchez, C. & Mach, B. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol Cell Biol 10, 965–971 (1990). · DOI
  31. Masternak, K., Muhlethaler-Mottet, A., Villard, J., Peretti, M. & Reith, W. Molecular genetics of the Bare lymphocyte syndrome. Rev Immunogenet 2, 267–282 (2000).
  32. Tammimies, K. et al. Ciliary dyslexia candidate genes DYX1C1 and DCDC2 are regulated by Regulatory Factor X (RFX) transcription factors through X-box promoter motifs. FASEB J 30, 3578–3587, https://doi.org/10.1096/fj.201500124RR (2016). · DOI
  33. Lubelsky, Y., Reuven, N. & Shaul, Y. Autorepression of rfx1 gene expression: functional conservation from yeast to humans in response to DNA replication arrest. Mol Cell Biol 25, 10665–10673, https://doi.org/10.1128/MCB.25.23.10665-10673.2005 (2005). · DOI
  34. Cathomen, T., Stracker, T. H., Gilbert, L. B. & Weitzman, M. D. A genetic screen identifies a cellular regulator of adeno-associated virus. Proc Natl Acad Sci USA 98, 14991–14996, https://doi.org/10.1073/pnas.261567198 (2001). · DOI
  35. Yan, Z. et al. Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers. Hum Gene Ther 26, 334–346, https://doi.org/10.1089/hum.2015.001 (2015). · DOI
  36. Gao, G. P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99, 11854–11859, https://doi.org/10.1073/pnas.182412299 (2002). · DOI · Paper page
  37. Nonnenmacher, M. & Weber, T. Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther 19, 649–658, https://doi.org/10.1038/gt.2012.6 (2012). · DOI · Paper page
  38. Siegrist, C. A. et al. RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol Cell Biol 13, 6375–6384 (1993). · DOI
  39. Moreno, C. S., Beresford, G. W., Louis-Plence, P., Morris, A. C. & Boss, J. M. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10, 143–151 (1999). · DOI
  40. Zhu, X. S. et al. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol Cell Biol 20, 6051–6061 (2000). · DOI
  41. Buckwold, V. E., Chen, M. & Ou, J. H. Interaction of transcription factors RFX1 and MIBP1 with the gamma motif of the negative regulatory element of the hepatitis B virus core promoter. Virology 227, 515–518, https://doi.org/10.1006/viro.1996.8360 (1997). · DOI
  42. Seguín-Estévez, Q. et al. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation. J Immunol 183, 2545–2553, https://doi.org/10.4049/jimmunol.0900376 (2009). · DOI
  43. Léger, A. et al. Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle. PLoS One 6, e20881, https://doi.org/10.1371/journal.pone.0020881 (2011). · DOI
  44. Cornille, F. et al. DNA binding properties of a chemically synthesized DNA binding domain of hRFX1. Nucleic Acids Res 26, 2143–2149 (1998). · DOI
  45. Agami, R. & Shaul, Y. The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes. Oncogene 16, 1779–1788, https://doi.org/10.1038/sj.onc.1201708 (1998). · DOI
  46. Smeenk, G. & Mailand, N. Writers, Readers, and Erasers of Histone Ubiquitylation in DNA Double-Strand Break Repair. Front Genet 7, 122, https://doi.org/10.3389/fgene.2016.00122 (2016). · DOI
  47. Chen, L. et al. Activation of protein kinase C induces nuclear translocation of RFX1 and down-regulates c-myc via an intron 1 X box in undifferentiated leukemia HL-60 cells. J Biol Chem 275, 32227–32233, https://doi.org/10.1074/jbc.M002645200 (2000). · DOI
  48. Dignam, J. D., Lebovitz, R. M. & Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11, 1475–1489 (1983). · DOI
  49. Grieger, J. C., Choi, V. W. & Samulski, R. J. Production and characterization of adeno-associated viral vectors. Nat Protoc 1, 1412–1428, https://doi.org/10.1038/nprot.2006.207 (2006). · DOI

Cited by

Sorted by citations

Metadata

Authors
Julien, L., Chassagne, J., Peccate, C., Lorain, S., Piétri-Rouxel, F., Danos, O., & Benkhelifa-Ziyyat, S.
Affiliations
  • Inserm (FR)
  • Hôpital Necker-Enfants Malades (FR)
Venue
Scientific Reports
Published
2018-01-09
Volume
8
Issue
1
Pages
210-210
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2781493226
Cited by
13
References
5
Citations by year
2026: 2 · 2024: 1 · 2022: 3 · 2020: 5 · 2018: 2
FWCI
1.07
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • University of Pennsylvania (p0001)
  • Institut National de la Santé et de la Recherche Médicale
  • Université Pierre et Marie Curie
  • Université de Genève
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
RFX1, RFX3, adeno-associated virus, inverted terminal repeats, d-sequences, transcription factors, protein-DNA interactions, AAV2, AAV1, viral transduction efficiency, transgene expression regulation, nuclear protein binding
MeSH terms
Regulatory Factor X Transcription Factors, Regulatory Factor X1, Dependovirus, Humans, Protein Binding, Transduction, Genetic, Terminal Repeat Sequences, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review